Interpace Biosciences Top Insiders
Interpace Biosciences employs about 147 people. The company is managed by 6 executives with a total tenure of roughly 7 years, averaging almost 1.0 years of service per executive, having 24.5 employees per reported executive. Examination of Interpace Biosciences' management performance can provide insight into the company performance.
| Thomas Burnell Insider CEO Pres |
| Sydney Finkelstein Insider Chief Officer |
Interpace |
Interpace Biosciences Management Team Effectiveness
The company has return on total asset (ROA) of (0.2602) % which means that it has lost $0.2602 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.8481) %, meaning that it created substantial loss on money invested by shareholders. Interpace Biosciences' management efficiency ratios could be used to measure how well Interpace Biosciences manages its routine affairs as well as how well it operates its assets and liabilities.Interpace Biosciences Workforce Comparison
Interpace Biosciences is rated second overall in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 864. Interpace Biosciences retains roughly 147 in number of employees claiming about 17% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.59) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.28) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.28. Interpace Biosciences Notable Stakeholders
An Interpace Biosciences stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Interpace Biosciences often face trade-offs trying to please all of them. Interpace Biosciences' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Interpace Biosciences' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Thomas Burnell | CEO Pres | Profile | |
| Sydney Finkelstein | Chief Officer | Profile | |
| Patrick Kane | VP Controller | Profile | |
| Jody Campbell | Chief Officer | Profile | |
| Thomas Freeburg | Chief Accounting Officer and Principal Accounting Officer | Profile | |
| Susanne Reilly | Chief Officer | Profile |
Interpace Biosciences Workforce Analysis
Traditionally, organizations such as Interpace Biosciences use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Interpace Biosciences within its industry.Interpace Biosciences Manpower Efficiency
Return on Interpace Biosciences Manpower
| Revenue Per Employee | 281K | |
| Revenue Per Executive | 6.9M | |
| Net Loss Per Employee | 101.7K | |
| Net Loss Per Executive | 2.5M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in Interpace OTC Stock
If you are still planning to invest in Interpace Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Interpace Biosciences' history and understand the potential risks before investing.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |